CN108478500A - A kind of composition and its application for oral cavity - Google Patents
A kind of composition and its application for oral cavity Download PDFInfo
- Publication number
- CN108478500A CN108478500A CN201810206265.5A CN201810206265A CN108478500A CN 108478500 A CN108478500 A CN 108478500A CN 201810206265 A CN201810206265 A CN 201810206265A CN 108478500 A CN108478500 A CN 108478500A
- Authority
- CN
- China
- Prior art keywords
- weight
- extract
- parts
- oral cavity
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000000214 mouth Anatomy 0.000 title claims abstract description 45
- 239000000203 mixture Substances 0.000 title claims abstract description 34
- 239000000284 extract Substances 0.000 claims abstract description 70
- 239000003814 drug Substances 0.000 claims abstract description 27
- 240000007164 Salvia officinalis Species 0.000 claims abstract description 19
- 235000002912 Salvia officinalis Nutrition 0.000 claims abstract description 18
- 235000002020 sage Nutrition 0.000 claims abstract description 18
- 229940116707 mentha piperita extract Drugs 0.000 claims abstract description 17
- 239000001331 rosmarinus officinalis leaf Substances 0.000 claims abstract description 17
- 229940034610 toothpaste Drugs 0.000 claims description 30
- 239000000606 toothpaste Substances 0.000 claims description 30
- 241000894006 Bacteria Species 0.000 claims description 22
- 244000179560 Prunella vulgaris Species 0.000 claims description 17
- 235000010674 Prunella vulgaris Nutrition 0.000 claims description 17
- -1 polyethylene Polymers 0.000 claims description 16
- 229940079593 drug Drugs 0.000 claims description 15
- 230000002401 inhibitory effect Effects 0.000 claims description 13
- 244000247747 Coptis groenlandica Species 0.000 claims description 12
- 235000002991 Coptis groenlandica Nutrition 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 12
- 239000004615 ingredient Substances 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 11
- 235000018958 Gardenia augusta Nutrition 0.000 claims description 10
- 235000004357 Mentha x piperita Nutrition 0.000 claims description 9
- 239000003921 oil Substances 0.000 claims description 9
- 235000019198 oils Nutrition 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical group O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 8
- 244000246386 Mentha pulegium Species 0.000 claims description 8
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 8
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 8
- 239000002324 mouth wash Substances 0.000 claims description 8
- 239000011734 sodium Substances 0.000 claims description 8
- 229910052708 sodium Inorganic materials 0.000 claims description 8
- 244000111489 Gardenia augusta Species 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 235000001050 hortel pimenta Nutrition 0.000 claims description 7
- 239000004698 Polyethylene Substances 0.000 claims description 6
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid group Chemical group C(C1=CC=CC=C1)(=O)O WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 6
- 229920000573 polyethylene Polymers 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 6
- 235000014749 Mentha crispa Nutrition 0.000 claims description 5
- 244000078639 Mentha spicata Species 0.000 claims description 5
- 239000004909 Moisturizer Substances 0.000 claims description 5
- 230000000740 bleeding effect Effects 0.000 claims description 5
- 235000013305 food Nutrition 0.000 claims description 5
- 230000001333 moisturizer Effects 0.000 claims description 5
- 239000002562 thickening agent Substances 0.000 claims description 5
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 claims description 4
- 241000605447 Anemarrhena Species 0.000 claims description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 4
- 235000003325 Ilex Nutrition 0.000 claims description 4
- 241000209035 Ilex Species 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- RCEAADKTGXTDOA-UHFFFAOYSA-N OS(O)(=O)=O.CCCCCCCCCCCC[Na] Chemical compound OS(O)(=O)=O.CCCCCCCCCCCC[Na] RCEAADKTGXTDOA-UHFFFAOYSA-N 0.000 claims description 4
- 241000246044 Sophora flavescens Species 0.000 claims description 4
- 235000009499 Vanilla fragrans Nutrition 0.000 claims description 4
- 244000263375 Vanilla tahitensis Species 0.000 claims description 4
- 235000012036 Vanilla tahitensis Nutrition 0.000 claims description 4
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 4
- 229930191283 anemarrhena Natural products 0.000 claims description 4
- 239000001913 cellulose Substances 0.000 claims description 4
- 229920002678 cellulose Polymers 0.000 claims description 4
- 239000008367 deionised water Substances 0.000 claims description 4
- 229910021641 deionized water Inorganic materials 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 4
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 4
- 229940051866 mouthwash Drugs 0.000 claims description 4
- 229940085605 saccharin sodium Drugs 0.000 claims description 4
- 239000000377 silicon dioxide Substances 0.000 claims description 4
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 claims description 4
- 239000004408 titanium dioxide Substances 0.000 claims description 4
- 229920001285 xanthan gum Polymers 0.000 claims description 4
- 239000000811 xylitol Substances 0.000 claims description 4
- 235000010447 xylitol Nutrition 0.000 claims description 4
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 4
- 229960002675 xylitol Drugs 0.000 claims description 4
- 239000005711 Benzoic acid Substances 0.000 claims description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 3
- 240000002853 Nelumbo nucifera Species 0.000 claims description 3
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 3
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 3
- 235000010233 benzoic acid Nutrition 0.000 claims description 3
- 239000011575 calcium Substances 0.000 claims description 3
- 229910052791 calcium Inorganic materials 0.000 claims description 3
- 229940067866 dandelion extract Drugs 0.000 claims description 3
- 235000020691 dandelion extract Nutrition 0.000 claims description 3
- 239000000796 flavoring agent Substances 0.000 claims description 3
- 235000019634 flavors Nutrition 0.000 claims description 3
- 239000004088 foaming agent Substances 0.000 claims description 3
- 235000003599 food sweetener Nutrition 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- 239000003765 sweetening agent Substances 0.000 claims description 3
- 239000001845 taraxacum officinale leaf extract Substances 0.000 claims description 3
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 2
- 108010011485 Aspartame Proteins 0.000 claims description 2
- 241000522254 Cassia Species 0.000 claims description 2
- 241000206575 Chondrus crispus Species 0.000 claims description 2
- 244000241257 Cucumis melo Species 0.000 claims description 2
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 claims description 2
- CTKXFMQHOOWWEB-UHFFFAOYSA-N Ethylene oxide/propylene oxide copolymer Chemical group CCCOC(C)COCCO CTKXFMQHOOWWEB-UHFFFAOYSA-N 0.000 claims description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 2
- 240000008375 Hymenaea courbaril Species 0.000 claims description 2
- KVCWSJZUKMSPLM-UHFFFAOYSA-N O.O[PH2]=O Chemical compound O.O[PH2]=O KVCWSJZUKMSPLM-UHFFFAOYSA-N 0.000 claims description 2
- 235000019082 Osmanthus Nutrition 0.000 claims description 2
- 241000333181 Osmanthus Species 0.000 claims description 2
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 2
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 2
- 239000004376 Sucralose Substances 0.000 claims description 2
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims description 2
- 244000223014 Syzygium aromaticum Species 0.000 claims description 2
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 claims description 2
- 125000002252 acyl group Chemical group 0.000 claims description 2
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 claims description 2
- 229910021502 aluminium hydroxide Inorganic materials 0.000 claims description 2
- 239000000605 aspartame Substances 0.000 claims description 2
- 235000010357 aspartame Nutrition 0.000 claims description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 2
- 229960003438 aspartame Drugs 0.000 claims description 2
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 claims description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 2
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 claims description 2
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 claims description 2
- 229940043256 calcium pyrophosphate Drugs 0.000 claims description 2
- 235000010418 carrageenan Nutrition 0.000 claims description 2
- 239000000679 carrageenan Substances 0.000 claims description 2
- 229920001525 carrageenan Polymers 0.000 claims description 2
- 229940113118 carrageenan Drugs 0.000 claims description 2
- 239000003086 colorant Substances 0.000 claims description 2
- 235000019821 dicalcium diphosphate Nutrition 0.000 claims description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 claims description 2
- 235000002864 food coloring agent Nutrition 0.000 claims description 2
- 239000000576 food coloring agent Substances 0.000 claims description 2
- 239000003205 fragrance Substances 0.000 claims description 2
- 239000003292 glue Substances 0.000 claims description 2
- 235000013922 glutamic acid Nutrition 0.000 claims description 2
- 239000004220 glutamic acid Substances 0.000 claims description 2
- 235000012907 honey Nutrition 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims description 2
- 235000021332 kidney beans Nutrition 0.000 claims description 2
- 239000001525 mentha piperita l. herb oil Substances 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 235000019477 peppermint oil Nutrition 0.000 claims description 2
- 239000002304 perfume Substances 0.000 claims description 2
- 229940044519 poloxamer 188 Drugs 0.000 claims description 2
- 229920001993 poloxamer 188 Polymers 0.000 claims description 2
- 235000010413 sodium alginate Nutrition 0.000 claims description 2
- 239000000661 sodium alginate Substances 0.000 claims description 2
- 229940005550 sodium alginate Drugs 0.000 claims description 2
- 229940065859 sodium cocoyl glycinate Drugs 0.000 claims description 2
- IKGKWKGYFJBGQJ-UHFFFAOYSA-M sodium;2-(dodecanoylamino)acetate Chemical compound [Na+].CCCCCCCCCCCC(=O)NCC([O-])=O IKGKWKGYFJBGQJ-UHFFFAOYSA-M 0.000 claims description 2
- 235000010199 sorbic acid Nutrition 0.000 claims description 2
- 239000004334 sorbic acid Substances 0.000 claims description 2
- 229940075582 sorbic acid Drugs 0.000 claims description 2
- 229940013618 stevioside Drugs 0.000 claims description 2
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 2
- 235000019202 steviosides Nutrition 0.000 claims description 2
- 235000019408 sucralose Nutrition 0.000 claims description 2
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 2
- 239000004094 surface-active agent Substances 0.000 claims description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- 241000050051 Chelone glabra Species 0.000 claims 1
- 244000007835 Cyamopsis tetragonoloba Species 0.000 claims 1
- 235000019270 ammonium chloride Nutrition 0.000 claims 1
- 229930189775 mogroside Natural products 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims 1
- 241000590002 Helicobacter pylori Species 0.000 abstract description 14
- 229940037467 helicobacter pylori Drugs 0.000 abstract description 14
- 230000001151 other effect Effects 0.000 abstract description 6
- 230000000694 effects Effects 0.000 description 28
- 208000024891 symptom Diseases 0.000 description 18
- 230000000052 comparative effect Effects 0.000 description 14
- 239000007788 liquid Substances 0.000 description 14
- 230000003110 anti-inflammatory effect Effects 0.000 description 13
- 230000008961 swelling Effects 0.000 description 13
- 208000002399 aphthous stomatitis Diseases 0.000 description 12
- 230000000844 anti-bacterial effect Effects 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 208000004371 toothache Diseases 0.000 description 10
- 230000036541 health Effects 0.000 description 9
- 241000196324 Embryophyta Species 0.000 description 8
- 239000003963 antioxidant agent Substances 0.000 description 8
- 230000003078 antioxidant effect Effects 0.000 description 8
- 235000006708 antioxidants Nutrition 0.000 description 8
- 240000003915 Lophatherum gracile Species 0.000 description 7
- 230000001754 anti-pyretic effect Effects 0.000 description 7
- 239000002221 antipyretic Substances 0.000 description 7
- 235000019441 ethanol Nutrition 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- 229920001817 Agar Polymers 0.000 description 6
- 241001570521 Lonicera periclymenum Species 0.000 description 6
- 239000008272 agar Substances 0.000 description 6
- 230000000259 anti-tumor effect Effects 0.000 description 6
- 230000000840 anti-viral effect Effects 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 230000004224 protection Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 241000193830 Bacillus <bacterium> Species 0.000 description 5
- 244000143590 Salvia chinensis Species 0.000 description 5
- 235000007154 Salvia chinensis Nutrition 0.000 description 5
- 235000005794 Salvia japonica Nutrition 0.000 description 5
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 5
- 208000025865 Ulcer Diseases 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 244000118350 Andrographis paniculata Species 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 241001529742 Rosmarinus Species 0.000 description 4
- 241000194017 Streptococcus Species 0.000 description 4
- 241000245665 Taraxacum Species 0.000 description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 4
- 229910052782 aluminium Inorganic materials 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 230000001900 immune effect Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 239000009955 niuhuang shangqing Substances 0.000 description 4
- 235000015424 sodium Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 206010006326 Breath odour Diseases 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- 240000001972 Gardenia jasminoides Species 0.000 description 3
- 208000032139 Halitosis Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 3
- 208000001431 Psychomotor Agitation Diseases 0.000 description 3
- 206010038743 Restlessness Diseases 0.000 description 3
- 244000178231 Rosmarinus officinalis Species 0.000 description 3
- 241000207929 Scutellaria Species 0.000 description 3
- QRYRORQUOLYVBU-VBKZILBWSA-N carnosic acid Chemical compound CC([C@@H]1CC2)(C)CCC[C@]1(C(O)=O)C1=C2C=C(C(C)C)C(O)=C1O QRYRORQUOLYVBU-VBKZILBWSA-N 0.000 description 3
- 230000002279 cholagogic effect Effects 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 229930003944 flavone Natural products 0.000 description 3
- 235000011949 flavones Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000012859 sterile filling Methods 0.000 description 3
- 235000007586 terpenes Nutrition 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- XHXUANMFYXWVNG-ADEWGFFLSA-N (-)-Menthyl acetate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(C)=O XHXUANMFYXWVNG-ADEWGFFLSA-N 0.000 description 2
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 2
- WITLAWYGGVAFLU-UHFFFAOYSA-N 3-(6-methoxy-1,3-benzodioxol-5-yl)-8,8-dimethylpyrano[2,3-f]chromen-4-one Chemical compound C1=CC(C)(C)OC2=CC=C(C(C(C3=CC=4OCOC=4C=C3OC)=CO3)=O)C3=C21 WITLAWYGGVAFLU-UHFFFAOYSA-N 0.000 description 2
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 2
- 208000010266 Aggressive Periodontitis Diseases 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 241000208828 Caprifoliaceae Species 0.000 description 2
- 244000035851 Chrysanthemum leucanthemum Species 0.000 description 2
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 241000245240 Lonicera Species 0.000 description 2
- 241001479543 Mentha x piperita Species 0.000 description 2
- 241000972672 Phellodendron Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 235000014676 Phragmites communis Nutrition 0.000 description 2
- 241000607764 Shigella dysenteriae Species 0.000 description 2
- 241000295644 Staphylococcaceae Species 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 208000037386 Typhoid Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000001986 anti-endotoxic effect Effects 0.000 description 2
- 230000003276 anti-hypertensive effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 238000004500 asepsis Methods 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 229940095731 candida albicans Drugs 0.000 description 2
- 108010079058 casein hydrolysate Proteins 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- 230000005713 exacerbation Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000000867 larynx Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000001771 mentha piperita Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 208000030194 mouth disease Diseases 0.000 description 2
- 201000006727 periodontosis Diseases 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000004302 potassium sorbate Substances 0.000 description 2
- 235000010241 potassium sorbate Nutrition 0.000 description 2
- 229940069338 potassium sorbate Drugs 0.000 description 2
- 235000013772 propylene glycol Nutrition 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001603 reducing effect Effects 0.000 description 2
- XDQITMCFPPPMBC-TUANDBMESA-N scutelloside Natural products OC[C@H]1O[C@@H](O[C@@H]2O[C@@H]3C[C@H]4[C@H](O)[C@@H](O)[C@@](O)(CO3)[C@@H]24)[C@H](O)[C@@H](O)[C@@H]1O XDQITMCFPPPMBC-TUANDBMESA-N 0.000 description 2
- 229940007046 shigella dysenteriae Drugs 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 230000003637 steroidlike Effects 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 150000003505 terpenes Chemical class 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 238000004879 turbidimetry Methods 0.000 description 2
- 201000008297 typhoid fever Diseases 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- 239000001605 (5-methyl-2-propan-2-ylcyclohexyl) acetate Substances 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- BOJKULTULYSRAS-OTESTREVSA-N Andrographolide Chemical compound C([C@H]1[C@]2(C)CC[C@@H](O)[C@]([C@H]2CCC1=C)(CO)C)\C=C1/[C@H](O)COC1=O BOJKULTULYSRAS-OTESTREVSA-N 0.000 description 1
- 241000605445 Anemarrhena asphodeloides Species 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- XUSYGBPHQBWGAD-PJSUUKDQSA-N Carnosol Chemical compound CC([C@@H]1C2)(C)CCC[C@@]11C(=O)O[C@@H]2C2=C1C(O)=C(O)C(C(C)C)=C2 XUSYGBPHQBWGAD-PJSUUKDQSA-N 0.000 description 1
- MMFRMKXYTWBMOM-UHFFFAOYSA-N Carnosol Natural products CCc1cc2C3CC4C(C)(C)CCCC4(C(=O)O3)c2c(O)c1O MMFRMKXYTWBMOM-UHFFFAOYSA-N 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 244000089795 Clausena lansium Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000037740 Coptis chinensis Species 0.000 description 1
- 241000037803 Coptis deltoidea Species 0.000 description 1
- 206010011469 Crying Diseases 0.000 description 1
- PQMOXTJVIYEOQL-UHFFFAOYSA-N Cumarin Natural products CC(C)=CCC1=C(O)C(C(=O)C(C)CC)=C(O)C2=C1OC(=O)C=C2CCC PQMOXTJVIYEOQL-UHFFFAOYSA-N 0.000 description 1
- XHXUANMFYXWVNG-UHFFFAOYSA-N D-menthyl acetate Natural products CC(C)C1CCC(C)CC1OC(C)=O XHXUANMFYXWVNG-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 208000005922 Glossalgia Diseases 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 208000002682 Hyperkalemia Diseases 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 206010021036 Hyponatraemia Diseases 0.000 description 1
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 235000017617 Lonicera japonica Nutrition 0.000 description 1
- 244000167230 Lonicera japonica Species 0.000 description 1
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 description 1
- 241001579180 Matthiola longipetala Species 0.000 description 1
- 208000036626 Mental retardation Diseases 0.000 description 1
- 241001072983 Mentha Species 0.000 description 1
- 244000173610 Mentha aquatica Species 0.000 description 1
- FSOGIJPGPZWNGO-UHFFFAOYSA-N Meomammein Natural products CCC(C)C(=O)C1=C(O)C(CC=C(C)C)=C(O)C2=C1OC(=O)C=C2CCC FSOGIJPGPZWNGO-UHFFFAOYSA-N 0.000 description 1
- 241001183990 Mesosphaerum suaveolens Species 0.000 description 1
- 206010028034 Mouth ulceration Diseases 0.000 description 1
- 241000123069 Ocyurus chrysurus Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 241001079007 Phellodendron chinense Species 0.000 description 1
- 240000002014 Phyllostachys nigra var. henonis Species 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 208000008350 Pruritus Vulvae Diseases 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 235000017276 Salvia Nutrition 0.000 description 1
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 description 1
- 240000004534 Scutellaria baicalensis Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- HKOIDIVCPUDLBS-UHFFFAOYSA-N Skullcapflavone II Natural products Oc1cccc(O)c1C2=CC(=O)c3c(O)c(O)c(O)c(O)c3O2 HKOIDIVCPUDLBS-UHFFFAOYSA-N 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 206010042170 Strangury Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 244000185386 Thladiantha grosvenorii Species 0.000 description 1
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 208000035868 Vascular inflammations Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 1
- HIMJIPRMECETLJ-UHFFFAOYSA-N Wogonin Natural products COc1cc(O)c(O)c2C(=O)C=C(Oc12)c3ccccc3 HIMJIPRMECETLJ-UHFFFAOYSA-N 0.000 description 1
- LNOHXHDWGCMVCO-UHFFFAOYSA-N Wogonoside Natural products C1=C(O)C(C(C=C(O2)C=3C=CC=CC=3)=O)=C2C(OC)=C1OC1OC(C(O)=O)C(O)C(O)C1O LNOHXHDWGCMVCO-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 206010001093 acute tonsillitis Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- AJXBTRZGLDTSST-UHFFFAOYSA-N amino 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)ON AJXBTRZGLDTSST-UHFFFAOYSA-N 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- ASLUCFFROXVMFL-UHFFFAOYSA-N andrographolide Natural products CC1(CO)C(O)CCC2(C)C(CC=C3/C(O)OCC3=O)C(=C)CCC12 ASLUCFFROXVMFL-UHFFFAOYSA-N 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Chemical class CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000002019 anti-mutation Effects 0.000 description 1
- 230000001857 anti-mycotic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000000884 anti-protozoa Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000002543 antimycotic Substances 0.000 description 1
- 239000003907 antipyretic analgesic agent Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 1
- 229940093265 berberine Drugs 0.000 description 1
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 208000020670 canker sore Diseases 0.000 description 1
- 206010061592 cardiac fibrillation Diseases 0.000 description 1
- 235000004654 carnosol Nutrition 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 230000002600 fibrillogenic effect Effects 0.000 description 1
- 210000003495 flagella Anatomy 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000009363 floriculture Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 208000017215 gastric mucosa-associated lymphoid tissue lymphoma Diseases 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229940094952 green tea extract Drugs 0.000 description 1
- 235000020688 green tea extract Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 238000009775 high-speed stirring Methods 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 229930014456 matrine Natural products 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 150000002729 menthone derivatives Chemical class 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 230000005404 monopole Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000004112 neuroprotection Effects 0.000 description 1
- 210000001331 nose Anatomy 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 201000001245 periodontitis Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 235000013930 proline Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 235000015639 rosmarinus officinalis Nutrition 0.000 description 1
- 230000001835 salubrious effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- GMQFOKBGMKVUQZ-UHFFFAOYSA-N scullcapflavone II Chemical compound COC1=CC=CC(O)=C1C1=CC(=O)C2=C(O)C(OC)=C(OC)C(OC)=C2O1 GMQFOKBGMKVUQZ-UHFFFAOYSA-N 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 229940048086 sodium pyrophosphate Drugs 0.000 description 1
- JAJWGJBVLPIOOH-IZYKLYLVSA-M sodium taurocholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(=O)NCCS([O-])(=O)=O)C)[C@@]2(C)[C@@H](O)C1 JAJWGJBVLPIOOH-IZYKLYLVSA-M 0.000 description 1
- 230000002557 soporific effect Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 1
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 1
- 210000005182 tip of the tongue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 230000004218 vascular function Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- XLTFNNCXVBYBSX-UHFFFAOYSA-N wogonin Chemical compound COC1=C(O)C=C(O)C(C(C=2)=O)=C1OC=2C1=CC=CC=C1 XLTFNNCXVBYBSX-UHFFFAOYSA-N 0.000 description 1
- LNOHXHDWGCMVCO-NTKSAMNMSA-N wogonin 7-O-beta-D-glucuronide Chemical compound C1=C(O)C(C(C=C(O2)C=3C=CC=CC=3)=O)=C2C(OC)=C1O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LNOHXHDWGCMVCO-NTKSAMNMSA-N 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
Abstract
The present invention relates to a kind of composition for oral cavity and its applications.The composition for oral cavity includes the component of following parts by weight:0.05 5 parts by weight of rosemary leaf extract;0.1 2.5 parts by weight of leaf of Mentha piperita extract;0.06 4 parts by weight of medicine extracts of Salvia officinalis leaves.Oral cavity can be not only cleaned provided by the present invention for the composition in oral cavity, also has both and removes oral helicobacter pylori, clearing heat and removing internal heat and other effects.
Description
Technical field
The present invention relates to a kind of composition for oral cavity and its applications, belong to daily chemical products technical field.
Background technology
Helicobacter pylori (Helicobacter pylori, H.pylori) is a kind of monopole, more flagellums, helically bent
Gram-negative bacteria, size be (0.3~1.0) μ m (2.0~5.0) μm.Helicobacter pylori is have high infection rate slow
Sexy metachromia pathogenic bacteria, Hp infection is infectious diseases, does not have " to carry " state.Hp infection is chronic active gastritis and digestion
The Etiological of property ulcer, it is closely related with the morbidity of gastric mucosa-associated lymphoid tissue lymphoma, gastric cancer.Some researches show that oral cavities
There are certain relevance between Hp in Hp and stomach, oral cavity may be another important aggregation ground of Hp, and find that oral cavity Hp feels
Dye person is easier that periodontosis occurs, and the recall rate of Hp and the severity of periodontosis and activity are proportionate in oral cavity.
Oral cavity occur pharyngodynia with dryness, two furious red, nasal cavities it is hot dry, nose is bleeding and dry glossalgia, swelling and aching of gum, oral cavity are burst
The symptoms such as ulcer and the tip of the tongue erosion, angular chilitis, aphthae, toothache, Chinese medicine are taken as " getting angry ".When people's operating pressure is big,
Diet is unhealthy, Smoking And Drinking, and often overtime work is stayed up late, and work and rest is irregular, and working environment is severe, and immunity is caused to reduce, and is just held
It gets angry in easy oral cavity.
It can be seen from the above, the helicobacter pylori in oral cavity has great harm to the health of human body;Oral cavity excessive internal heat pair
People’s lives quality has the negative effect that can not be ignored, and the happiness of people's daily life is made to reduce.In order to restore as early as possible
The oral environment of health, people's generally use drug therapy solve the above problems.But drug administration can cause human body certain
Side effect, it is therefore necessary to provide other external treatment modes to solve unhealthy phenomenon existing for the oral cavity of part.
Invention content
To solve the above-mentioned problems, the present invention provides a kind of dental products, can not only clean oral cavity, also have both removing
Oral helicobacter pylori, clearing heat and removing internal heat and other effects.
The present invention adopts the following technical scheme that realization.
A kind of composition for oral cavity includes the component of following parts by weight:
Rosemary leaf extract 0.05-5 parts by weight;
Leaf of Mentha piperita extract 0.1-2.5 parts by weight;
Medicine extracts of Salvia officinalis leaves 0.06-4 parts by weight.
Preferably, the composition for oral cavity includes the component of following parts by weight:
Rosemary leaf extract 0.2-3 parts by weight;
Leaf of Mentha piperita extract 0.2-1.5 parts by weight;
Medicine extracts of Salvia officinalis leaves 0.1-2 parts by weight.
Further preferably, the composition for oral cavity includes the component of following parts by weight:
Rosemary leaf extract 0.8-1.2 parts by weight;
Leaf of Mentha piperita extract 0.2-0.8 parts by weight;
Medicine extracts of Salvia officinalis leaves 1.2-1.6 parts by weight.
In the present invention, the rosemary (Rosmarinus officinalis L.) also known as oil grass, alias ocean it
Dew, tansy etc..It is rosemary fragrant odour, strong, refrigerant, it is Labiatae Rosmarinus, perennial evergreen undershrub plant, master
The chemical composition wanted includes terpene, flavonoids, organic acid, aliphatic acid, multibranched paraffin, boots matter and amino acid etc..Wherein, phenol two
Carnosic acid and carnosol in terpene are most important antioxidant contents.Rosemary is a kind of important natural perfume plant,
It is widely used in the fields such as daily-use chemical industry, food additive adduction medicines and health protection.It is rich in a variety of antioxidant contents efficiently, safe,
It is a kind of generally acknowledged at present plant having compared with high anti-oxidation effect, can effectively removes interior free yl.Rosemary is potent
Anti-corrosive antibacterial acts on.Rosemary Oil has sterilization, desinsection, anti-inflammatory isoreactivity.It is the excellent inoxidizability of Rosmarinus officinalis extract, resistance to
The characteristics such as thermal stability, high-efficiency broad spectrum will be such that it has in food, medicine and health products, cosmetic field more wide
Application prospect.
Rosemary leaf extract of the present invention, can be used the method extraction of this field routine, or be passed through by rosemary leave
65% ethyl alcohol is with solid-to-liquid ratio (mg/L) 1:10 impregnate made from gained extract.
Peppery peppermint (Mentha piperita L.) is first generation sterile variety made of fish mint hybridizes with spearmint, is
Labiatae Mentha herbaceos perennial, alias Europe peppermint, pennyroyal mint, American mint.The plant has inducing diaphoresis, evacuation wind
The effects that heat, pharynx-clearing throat-benefiting, cool health care product have essential wind oil, white flower oil etc. made of it.As natural rare spice crop,
The essential oil that its cauline leaf refines is widely used in luxury food, superior cosmetics and medical and health etc. because quality is excellent.Mainly
Containing 118 kinds of ingredients such as menthones, menthol, menthyl acetate, aroma of pure is salubrious pleasant.In addition, peppery peppermint is to golden yellow
Staphylococcus, Escherichia coli, Pseudomonas aeruginosa etc. have inhibiting effect.
Leaf of Mentha piperita extract of the present invention, can be used the method extraction of this field routine, or be passed through by leaf of Mentha piperita
65% ethyl alcohol is with solid-to-liquid ratio (mg/L) 1:10 impregnate made from gained extract.
Salvia japonica (Salvia officinalis) is Labiatae, salvia, a biennial or perennial herb
Plant and evergreen dwarf shrub, leaf, stem and Hua Junyou very high utility value.Salvia japonica has limpid fragranced, can be used for expecting
Reason, tea-drinking, beauty, health, essential oil, floriculture etc.;Have anti-corrosion, antibacterial, remove free radical, it is anti-oxidant, it is anti-mutation, strengthen nerve,
Antipyretic, body-building promotes digestion anti-inflammatory, protection stomach and adjusts immune and other effects.Salvia japonica is very ancient medicinal in Europe
The Fragrant vegetables of plant or the low aluminium of a kind of hyperkalemia hyponatremia, high calcium.So Salvia japonica integrates edible, medicinal and health care,
It is widely paid close attention to, becomes a research hotspot.
The method extraction of this field routine can be used in medicine extracts of Salvia officinalis leaves of the present invention, or by medicine Salvia japonica
Leaf is through 65% ethyl alcohol with solid-to-liquid ratio (mg/L) 1:10 impregnate made from gained extract.
Preferably, the composition further includes rhizoma anemarrhenae, Cortex Phellodendri, radix scutellariae, the coptis, kuh-seng, cape jasmine, Prunella vulgaris, lophatherum gracile, wears
One or more of heart lotus, honeysuckle, dandelion.
Wherein, dosage is each component in the composition:
It is further preferred that the composition for oral cavity includes the component of following parts by weight:
It is further preferred that the composition for oral cavity includes the component of following parts by weight:
It can further significantly it is an unexpected discovery of the invention that adding one or more of above-mentioned raw materials in above-mentioned composition
The effect of improving composition.
Above-mentioned rhizoma anemarrhenae be liliaceous plant rhizoma anemarrhenae (Anemarrhena asphodeloides Bge) rhizome, bitter,
It is cold in nature, return lung, stomach, kidney channel.With clearing heat-fire, nourishing Yin and moistening dryness, relieving restlessness and other effects of quenching the thirst.Contain a large amount of steroidals in Asphodeloides Bge Rhizome
Saponin(e, double benzene pyrrones, lignanoids, polysaccharide, organic acid, a large amount of mucilaginous substances and trace element etc..With anti-inflammatory, anti-
Bacterium, antiviral, anti-platelet aggregation, hypoglycemic, antitumor, anti-aging and anti-dull-witted, anti-oxidant, antidepression, improvement sclerotin are dredged
The effects that loose.
Cortex Phellodendri is the dry bark of rutaceae wampee (Phellodendron chinense Schneid.).It practises
Claim " CORTEX PHELLODENDRI CHINENSE ".Cortex Phellodendri bitter trembles with fear, returns kidney, bladder warp.With heat-clearing and damp-drying drug, purging intense heat, except steaming, detoxification sore treatment and other effects.There is tune
The effects that saving blood glucose, gastrointestinal function, blood pressure lowering, antibacterial, anti-inflammatory, antipyretic, antitumor, adjusting promoted to be immunized and is anti-oxidant.Cortex Phellodendri
Extract is for treating department of stomatology common disease, such as periodontitis, acute ulcerative gingivitis, stomatocace, swelling and aching of gum
Deng, have antibacterial anti-inflammatory, heat-clearing treat sore, wound healing the effect of.As it is common cure mainly aphthae prescription it is important in
Medicine is used widely.
Radix scutellariae is the dry root of labiate radix scutellariae (Scutellaria baicalensis Georgi).Radix scutellariae is containing Huang
A kind of reed mentioned in ancient books aglycon, scutelloside, wogonin, wogonoside, neobaicalein, acetophenone, palmitic acid, oleic acid, proline, benzoic acid, Huang
A kind of reed mentioned in ancient books enzyme, cupreol.Modern research shows that radix scutellariae is to hemolytic streptococcus, Diplococcus pneumopniae, influenza virus, typhoid bacillus, dysentery
Shigella, Pseudomonas aeruginosa, tubercle bacillus, staphylococcus aureus have inhibiting effect.Draft additive of the scutelloside as toothpaste
There are hemostasis, anti-inflammatory, except a variety of curative effects such as halitosis and callus.
The coptis is the ranunculaceae plant coptis (Coptis chinensis Franch.), the triangle leaf coptis (Coptis
Deltoidea C.Y.Cheng et Hsiao) or cloud connect (Coptis teeta Wall.) dry rhizome.The coptis mainly has
There is many-sided effect such as antibacterial, antiviral, antiendotoxin, antiprotozoan, can inhibit.Jamaicin in the coptis, to a variety of leather orchid
Positive and negative bacterium has inhibiting effect.Berberine has obvious inhibiting effect to helicobacter pylori in vitro, cheap,
Safety is good.
Kuh-seng is the dry root of legume kuh-seng (Sophora flavescens Ait.).First recorded in《Legendary god of farming's book on Chinese herbal medicine
Through》, middle product are classified as, taste is extremely bitter, cold in nature, has the effects that heat-clearing and damp-drying drug, desinsection, diuresis.Kuh-seng belongs to the heat-clearing in antipyretic
Eliminating dampness medicine is used for hot dysentery, has blood in stool, jaundice renal shutdown, leukorrhea with reddish discharge, swelling of vulva pruritus vulvae, eczema, wet sore, pruitus, mange leprosy.
The main pharmacological of kuh-seng has anti-arrhythmia, resisting myocardial fibrillation, antitumor, anti-inflammatory, resisting pathogenic microbes, anti-liver injury
And the adjustment effect etc. to immune system and nervous system.Matrine has inhibiting effect, kuh-seng water to drug resistance helicobacter pylori
Decocting liquid to Escherichia coli, staphylococcus aureus, alpha streptococcus, beta streptococcus, shigella dysenteriae, dimension from dysentery Salmonella with
And proteus has obvious inhibiting effect.
Cape jasmine is the dry mature fruit of madder wort cape jasmine (Gardenia jasminoides Ellis).Bitter,
It is cold in nature.The thoughts of returning home, lung, tri-jiao channel.With purging intense heat relieving restlessness, clearing heat and promoting diuresis, removing pattogenic heat from the blood and toxic material from the body and other effects.Cape jasmine has anti-inflammatory, antipyretic, town
Bitterly, the effects that liver protection, cholagogic, reducing blood lipid, antithrombotic, neuroprotection, tranquilizing soporific.Clinic is widely used in Vexed, jaundice
Urinate the cards such as red, blood strangury and dry pain, blood-head tells nosebleed, red eye, swell pain, pathogenic fire,toxin and furuncles;Its root functionality heat-clearing, cool blood, removing toxic substances, it is civil main
Treatment for illnesss such as icterepatitis, nephritic dropsy, flu high fever, bleeding haematemesis, traumatic injury, sore swollen toxins;Ye Ke
Swelling and pain relieving treats traumatic injury;Flower can the hot cool blood lipid-loweringing of clearing lung-heat, treatment cough with lung heat, nosebleed epistaxis.Also treatment oral cavity is useful for burst
The report of ulcer.
Prunella vulgaris is the drying fruit ear of labiate Prunella vulgaris (Prunella vulgaris L.).Change in Prunella vulgaris
Study point includes mainly the multiclass ingredients such as triterpene, steroidal, flavones, cumarin, organic acid.Prunella vulgaris has apparent anti-inflammatory antipyretic
Analgesic activity has very strong resistant function, extract and active constituent sieve danshinolic acid to mitigating vascular inflammation Earlier period of inflammation
And periodontal disease etc. all has certain effect.Prunella vulgaris is other than it can inhibit the nonspecific mental retardation of inflammatory reaction, to spy
Specific immunological also shows great inhibiting effect.In addition, finding that Prunella vulgaris water decoction is anti-with wide spectrum by experiment in vitro
Bacterium activity, gram-Negative bacillus and gram-positive bacteria are all had a strong inhibitory effect, to shigella dysenteriae, typhoid bacillus,
Comma bacillus, Escherichia coli, Pseudomonas aeruginosa and staphylococcus, streptococcus etc. have inhibiting effect, and its flooding agent is to certain normal
The pathogenic dermatophyte seen also has certain inhibiting effect.Prunella vulgaris stem, leaf, fringe and herb have antihypertensive effect, study table
Bright Prunella vulgaris antihypertensive effect is related with Prunella vulgaris total saposins.Prunella vulgaris is also antiviral, hypoglycemic, reducing blood lipid, antitumor, antioxygen
The effects that change, Green Tea Extract, calm, hypnosis.
Lophatherum gracile is the drying cauline leaf of grass henon bamboo leaf (Lophatherum gracile Brongn.).Sweet in flavor,
It is light, it is cold in nature.The thoughts of returning home, stomach, small intestinl channel.With clearing heat-fire, the effect of relieving restlessness is quenched the thirst, inducing diuresis for treating strangurtia.Containing a large amount of in lophatherum gracile
Flavone compound and bioactive polysaccharide and other active components, in phenolic acid compound, anthraquinone analog compound, terpene
Ester, amino acid and manganese, zinc, selenium and other trace elements.Modern pharmacology proves that lophatherum gracile has antipyretic, diuresis, antibacterial action, clinically
It is usually used in treating pyreticosis polydipsia, aphthae, swelling and aching of gum, children's crying with fear, cough with lung heat, stomach hot vomiting, hot urination stranguria with turbid discharge
Deng card.In addition to it can be used for medicinal purpose, lophatherum gracile can be additionally used in the fields such as health care of food product.Herba Lophatheri extract is added to oral care
In articles for use, bleeding gums symptom is can obviously improve, achievees the purpose that preventing oral cavity gets angry.
Herba Andrographitis is the drying of acanthaceous plant Herba Andrographitis (Andrographis paniculata (Burm.f.) Nees)
Aerial part.Bitter, it is cold in nature;The thoughts of returning home, lung, large intestine, bladder warp have effects that clearing heat and detoxicating, cool blood detumescence, are widely used in
Treat bacillary dysentery, acute tonsillitis, influenza and venomous snake bite etc..Main component contain diterpenoid-lactone, sterol,
Flavone compound, alkaloid etc..Andrographolide have it is antipyretic, analgesia, it is anti-inflammatory, antitumor, antiviral, anti-oxidant, immune
Adjusting and Hepatocyte protection.The treatment of inflammation-related diseases, such as larynx are widely used in China and Asia other countries at present
The scorching, infection of the upper respiratory tract and rheumatic arthritis.Have it is experimentally confirmed that Andrographis Paniculata can treat canker sore.
Honeysuckle is Caprifoliaceae (Caprifoliaceae) Lonicera (Lonicera Linn.) plant honeysuckle (Lonicera
Japonica Thunb.) dry flower, be conventional Chinese medicine, applicating history is long, there is the effect of clearing heat and detoxicating, wind-heat dissipating.
It is clinically used for ulcerative carbuncle, larynx numbness, warm blood fulminant dysentery, anemopyretic cold, warm disease heating etc..Honeysuckle flower water or ethanol extract have more wide
General pharmacological action includes mainly anti-inflammatory, antipyretic, antibacterial, antiviral, antimycotic, antiendotoxin, decompression, hepatic cholagogic, antibiosis
It educates, is anti-oxidant, hemostasis and immunological regulation etc..Honeysuckle plays the role of clearing heat and removing internal heat, anti-inflammatory analgetic in toothpaste and removes halitosis.
Dandelion is feverfew dandelion (TaraxacummongolicumHand.-Mazz.), alkali ground dandelion
(TarxacumborealisinenseKitam.) or the drying herbs of several plants is belonged to.For broad spectrum antimicrobial agent, have anti-true
Bacterium, protection stomach and intestine, blood glucose, improves vascular function, immunological regulation, resists antiviral, anti-inflammatory, anti-oxidant, antitumor, hepatic cholagogic
The effects that tired.It can inhibit the growth of oral cavity Hp in the oral cavity, treatment recurrent oral ulceration, remove halitosis;Taking can be with
Treat gastric and duodenal ulcer etc..
Above-described rhizoma anemarrhenae, Cortex Phellodendri, radix scutellariae, the coptis, kuh-seng, cape jasmine, Prunella vulgaris, lophatherum gracile, Herba Andrographitis, honeysuckle,
The required extract of the present invention is prepared using aqueous extraction-alcohol precipitation technology in dandelion.Preferably, the solid-to-liquid ratio of liquid and solvent
(mg/L) it is 1:10.
The present invention also provides the compositions described in an any of the above-described technical solution to prepare for treating bleeding gums, suppression
Application in the oral care product of oral bacteria processed.
The present invention provides a kind of toothpaste, includes the component of following parts by weight:
Active component:
Rosemary leaf extract 0.05-5 parts by weight;
Leaf of Mentha piperita extract 0.1-2.5 parts by weight;
Medicine extracts of Salvia officinalis leaves 0.06-4 parts by weight;
Auxiliary material:
Preferably, the toothpaste includes the component of following parts by weight:
Active component:
Rosemary leaf extract 0.2-3 parts by weight;
Leaf of Mentha piperita extract 0.2-1.5 parts by weight;
Medicine extracts of Salvia officinalis leaves 0.1-2 parts by weight;
Auxiliary material:
The rubbing agent is selected from silica, hypophosphite monohydrate hydrogen calcium, calcium phosphate dibasic anhydrous, calcium carbonate, aluminium hydroxide, chlorination
One or more of sodium or calcium pyrophosphate;
The moisturizer is selected from sorb (sugar) alcohol, glycerine, propylene glycol, polyethylene glycol-8 or one kind or several in butanediol
Kind;
The foaming agent is selected from lauryl sodium sulfate, sodium lauroyl sarcosine, sodium cocoyl glycinate, acyl glutamic acid
One or more of sodium or cocounut oil acyl methyl taurine sodium;
The thickener is selected from cellulose and its derivates, melon glue, sodium alginate, xanthans, guar gum hydroxypropyl three
One or more of ammonio methacrylate, carrageenan or locust tree fresh kidney beans;
The sweetener is selected from saccharin sodium, Sucralose, xylitol, honey element, Aspartame, stevioside or sweet Momordica grosvenori
One or more of glycosides;
The essence is selected from one or more of vanilla, spearmint, minty note or Chinese ilex peppermint;
The one kind or several of the preservative in benzoic acid and its esters, sorbic acid and its esters or parabens
Kind;
The appearance modifying agents are selected from titanium dioxide, food coloring, food color lake or one or more of the particle that cleans the teeth;
The solvent is selected from deionized water.
Preferably, the toothpaste further includes a kind of following ingredient:
The present invention also provides a kind of preparation methods of above-mentioned toothpaste, including:Above-mentioned composition is mixed, toothpaste is made.Tool
Steps are as follows for body:
A, by rosemary leaf extract, leaf of Mentha piperita extract, medicine extracts of Salvia officinalis leaves, be dissolved in moisturizer, it is high
Speed stirring, is prepared into the first mixed liquor;
B, thickener is added in the first mixed liquor, stirring obtains the second mixed liquor;
C, appearance modifying agents are added into the second mixed liquor, stirs, obtains third mixed liquor;
D, third mixed liquor, sweetener, rubbing agent, essence, foaming agent, preservative are added into solvent, stirring obtains the
Four mixed liquors;
E, the 4th mixed liquor continues to stir at vacuum condition 0.08-0.12MPa, and lotion is made;
F, it examines, sterile filling enters in aluminum plastic composite pipe, seals, and toothpaste is made.
The present invention also provides a kind of mouthwashes, include the component of following parts by weight:
Active component:
Rosemary leaf extract 0.05-5 parts by weight;
Leaf of Mentha piperita extract 0.1-2.5 parts by weight;
Medicine extracts of Salvia officinalis leaves 0.06-4 parts by weight;
Auxiliary material:
The solvent is selected from deionized water;
The moisturizer is selected from one or more of sorb (sugar) alcohol, propylene glycol, glycerine, polyethylene glycol-8;
The surfactant is selected from poloxamer188, lauryl sodium sulfate, sodium lauroyl sarcosine, cocounut oil acyl first
One or more of base sodium taurocholate;
The thickener is selected from one or more of cellulose, card wave, carragheen;
The food flavor is selected from cloves, Chinese cassia tree perfume, fragrance of osmanthus, peppermint oil, vanilla, spearmint, minty note, Chinese ilex
One or more of peppermint;
The colorant is selected from one or more of green, blue, red.
It is furthermore preferred that above-mentioned mouthwash further includes following ingredient:
Technical solution of the present invention has the advantages that:
The present invention gives full play to the synergistic function between each ingredient so that institute using the different medical mechanism of each ingredient
The composition obtained can remove oral helicobacter pylori, while also have effects that clearing heat and removing internal heat.
Specific implementation mode
The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention..
A kind of compositions for oral cavity of embodiment 1-4
The formula of comparative example 1~3 and Examples 1 to 3 is shown in Table 1.
Table 1:Formula
Examples 1 to 3 is composition provided by the invention in table 1, when specifically used, can be mixed with auxiliary material appropriate
At oral preparations such as toothpaste or mouthwashes.
A kind of compositions for oral cavity of embodiment 4-7
The formula of comparative example 4~7 and embodiment 4~7 is shown in Table 2.
Table 2:Formula
Embodiment 4~7 is composition provided by the invention in table 2, when specifically used, can be mixed with auxiliary material appropriate
At oral preparations such as toothpaste or mouthwashes.
A kind of toothpaste of embodiment 9-12
For the advantageous effect that the present invention is further explained, the present invention is by comparative example 1~3, the combination in Examples 1 to 3
Object and auxiliary material appropriate, are prepared into toothpaste.
(1) formula of comparative example 8~10 and embodiment 8~10 is shown in Table 3.
Table 3:Formula
(2) preparation method (when being free of certain ingredient in certain toothpaste, the ingredient is not added in preparation process) of toothpaste
A, by rosemary leaf extract, leaf of Mentha piperita extract, medicine extracts of Salvia officinalis leaves be dissolved in sorb (sugar) alcohol and
In polyethylene glycol-8, high-speed stirred 10min is prepared into the first mixed liquor;
B, xanthans is added in the first mixed liquor, stirs 10min, obtains the second mixed liquor;
C, titanium dioxide is added in the second mixed liquor, is stirred 10min, is obtained third mixed liquor;
D, third mixed liquor be added water, saccharin sodium, xylitol, silica, minty note, cocounut oil acyl methyl taurine sodium,
Potassium sorbate stirs the 4th mixed liquors of 10min;
E, the 4th mixed liquor continues to stir 15min in the case where vacuum condition is 0.08-0.12MPa, and lotion is made;
F, it examines, sterile filling enters in aluminum plastic composite pipe, seals, and toothpaste is made.
Compliance test result 1
(1) human trial (oral cavity excessive internal heat)
The inclusion criteria of experimental subjects is:Between age 18-65 Sui, remaining tooth >=16 tooth in mouth, no systemic disease, merely
Oral cavity get angry, adjoint symptom is:Swelling and aching of gum, toothache, aphthae these symptoms crowd.
Experimental subjects participates in the normal individual trial experiment of toothpaste, is grouped at random according to test specimen number, every group of 25 people, respectively
Group is respectively using toothpaste described in embodiment 8-10 and comparative example 8-10, and daily sooner or later respectively using once, observation uses the mouth after 7d
Chamber recovery situation.
Curative effect determinate standard is as follows:
It is effective:Swelling and aching of gum, toothache, aphthae these symptoms disappearance, and no relapse after two weeks.
Effectively:Swelling and aching of gum, toothache, aphthae these symptoms make moderate progress, but do not completely eliminate.
In vain:Excessive internal heat symptom in patient oral cavity is not alleviated, still has swelling and aching of gum, toothache, aphthae these symptoms, even
Exacerbation of symptoms.
Treat total effective rate=(effective+effective)/total number of cases × 100%.
As a result such as table 4:
(2) human trial (removing oral helicobacter pylori)
By comparative example 1~3, the sterile liquid of equivalent is respectively prepared in composition described in Examples 1 to 3, is packed into sterile test tube
In it is spare;
Choose the following strain for causing mouth disease:Helicobacter pylori, gold-coloured staphylococci, Candida albicans, deformation hammer
Bacterium;Choose caseinhydrolysate (MH) meat soup, agar medium.Standard strain takes a ring after passing on pure culture, with oese
Strain is inoculated in 37 DEG C of constant incubator cultures in MH broth bouillons and identifies bacterium amount through turbidimetry and count for 6 hours.It takes identical
Amount cultivates 6 hours test bacteria liquids, and bacterium solution is spread evenly across to MH agar plate surfaces respectively with sterile cotton swab, slightly dry rear use
Aseptic nipper distinguishes the circle filter paper of the sterile liquid of draws equal amounts comparative example 1~3 and Examples 1 to 3, and note is in MH agar plate tables
Antibacterial circle diameter (mm) is observed and measured to face, 37 DEG C of insulating box cultures in 24 hours, and bacteriostatic experiment is repeated 3 times, and antibacterial result is 3 times
Laboratory mean values obtain 5 result of table.
As a result such as table 5:
The MH broth bouillons containing equivalent comparative example 1~3 and Examples 1 to 3 sterile liquid medicine are taken, are inoculated with equivalent respectively
Test bacterium solution 0.05ml (105CFU/ml), and with sterile MH broth bouillons identical strain is inoculated with as a contrast, in 37 DEG C of constant temperature
Case culture is obtained after 24 hours such as 6 conclusion of table.
As a result such as table 6:
" +++ " bacterium obviously grows;"+" bacterium reduces growth;" 0 " takes culture medium in inoculation asepsis growth.
Above-mentioned experiment can confirm that the present invention has helicobacter pylori certain inhibiting effect, at the same time, moreover it is possible to press down
The growth of other bacteriums in donsole chamber.
A kind of toothpaste of embodiment 11-14
For the advantageous effect that the present invention is further explained, the present invention is by comparative example 4~7, the combination in embodiment 4~7
Object and functional auxiliary materials appropriate, are prepared into toothpaste, pedestrian's body proof test of going forward side by side, and the beneficial effect of the present invention is proved deeper into ground
Fruit.
(1) formula of comparative example 11~14 and embodiment 11~14 is shown in Table 7.
As a result such as table 7:
Table 7:Formula
(2) not preparation method (when being free of certain ingredient in certain toothpaste, the ingredient is not added in preparation process)
A, rosemary leaf extract, leaf of Mentha piperita extract, medicine extracts of Salvia officinalis leaves, anemarrhena asphodefoides extract, Cortex Phellodendri are carried
It takes object, Baical Skullcap root P.E, coptis extract, shrubby sophora extract, capejasmine extract, Prunella vulgaris extract, Herba Lophatheri extract, wear
Heart lotus extract, Honegsukle flower P.E, dandelion extract are dissolved in sorb (sugar) alcohol and polyethylene glycol-8, high-speed stirred
10min is prepared into the first mixed liquor;
B, xanthans is added in the first mixed liquor, stirs 10min, obtains the second mixed liquor;
C, titanium dioxide is added in the second mixed liquor, is stirred 10min, is obtained third mixed liquor;
D, third mixed liquor be added water, saccharin sodium, xylitol, silica, minty note, cocounut oil acyl methyl taurine sodium,
Potassium sorbate stirs the 4th mixed liquors of 10min;
E, the 4th mixed liquor continues to stir 15min in the case where vacuum condition is 0.08-0.12MPa, and lotion is made;
F, it examines, sterile filling enters in aluminum plastic composite pipe, seals, and toothpaste is made.
Compliance test result 2
(1) human trial (oral cavity excessive internal heat)
The inclusion criteria of experimental subjects is:Between age 18-65 Sui, remaining tooth >=16 tooth in mouth, no systemic disease, merely
Oral cavity get angry, adjoint symptom is:Swelling and aching of gum, toothache, aphthae these symptoms crowd.
Experimental subjects participates in the normal individual trial experiment of toothpaste, is grouped at random according to test specimen number, every group of 25 people, respectively
Group is respectively using toothpaste described in embodiment 11-14 and comparative example 11-14, and daily sooner or later respectively using once, observation uses after 7d
Oral cavity recovery situation.
Curative effect determinate standard is as follows:
It is effective:Swelling and aching of gum, toothache, aphthae these symptoms disappearance, and no relapse after two weeks.
Effectively:Swelling and aching of gum, toothache, aphthae these symptoms make moderate progress, but do not completely eliminate.
In vain:Excessive internal heat symptom in patient oral cavity is not alleviated, still has swelling and aching of gum, toothache, aphthae these symptoms, even
Exacerbation of symptoms.
Treat total effective rate=(effective+effective)/total number of cases × 100%.
As a result such as table 8:
In order to prove the effect of the present invention, 25 people for meeting above-mentioned standard are chosen as experimental subjects, take Niuhuang Shangqing
Piece is compared with above-described embodiment 12, and the crowd of 12 groups of embodiment improvement phenomenon occurs better than taking Niuhuang Shangqing Tablets after 2d
Group, two groups of effective percentage is essentially identical after 7d.It gets angry when with simple oral cavity, adjoint symptom is:Gum is red and swollen, toothache,
Using the toothpaste of the present invention while crowd of these symptoms of aphthae takes Niuhuang Shangqing Tablets, the improvement phenomenon after 2d is apparent
Toothpaste of the present invention is used with simple better than simple Niuhuang Shangqing Tablets of taking, and the effective percentage after 7d has reached 100%.
(2) human trial (inhibiting helicobacter pylori)
By comparative example 4~7, the sterile liquid of equivalent is respectively prepared in embodiment 4~7, is fitted into spare in sterile test tube;
Choose the following strain for causing mouth disease:Helicobacter pylori, gold-coloured staphylococci, Candida albicans, deformation hammer
Bacterium;Choose caseinhydrolysate (MH) meat soup, agar medium.Standard strain takes a ring after passing on pure culture, with oese
Strain is inoculated in 37 DEG C of constant incubator cultures in MH broth bouillons and identifies bacterium amount through turbidimetry and count for 6 hours.It takes identical
Amount cultivates 6 hours test bacteria liquids, and bacterium solution is spread evenly across to MH agar plate surfaces respectively with sterile cotton swab, slightly dry rear use
Aseptic nipper distinguishes the circle filter paper of the sterile liquid of draws equal amounts comparative example 4~7 and embodiment 4~7, and note is in MH agar plate tables
Antibacterial circle diameter (mm) is observed and measured to face, 37 DEG C of insulating box cultures in 24 hours, and bacteriostatic experiment is repeated 3 times, and antibacterial result is 3 times
Laboratory mean values obtain 9 result of table.
As a result such as table 9:
The MH broth bouillons containing 4~7 liquid of equivalent comparative example 4~7 and embodiment are taken, are inoculated with the experiment of equivalent respectively
Bacterium solution 0.05ml (105CFU/ml it), and with sterile MH broth bouillons is inoculated with identical strain as a contrast, is trained in 37 DEG C of insulating boxs
It is obtained such as following table conclusion after supporting 24 hours.
As a result such as table 10:
" +++ " bacterium obviously grows;"+" bacterium reduces growth;" 0 " takes culture medium in inoculation asepsis growth.
The above results are it is found that further add anemarrhena asphodefoides extract, phellodendron extract, Baical Skullcap root P.E, coptis extract, hardship
Conopsea extraction, capejasmine extract, Prunella vulgaris extract, Herba Lophatheri extract, Andrographis Paniculata, Honegsukle flower P.E, Pu Gong
English extract can make the present invention of gained obtain more effect, i.e., anemarrhena asphodefoides extract, phellodendron extract, Baical Skullcap root P.E,
Coptis extract, shrubby sophora extract, capejasmine extract, Prunella vulgaris extract, Herba Lophatheri extract, Andrographis Paniculata, gold and silver
It flower extract, dandelion extract and is made of rosemary leaf extract, leaf of Mentha piperita extract, medicine extracts of Salvia officinalis leaves
There is synergistic function between composition.
A kind of mouthwashes of embodiment 15-21
The formula of embodiment 15~21 is shown in Table 11.
Table 11:Formula
Although above the present invention is described in detail with a general description of the specific embodiments,
On the basis of the present invention, it can be made some modifications or improvements, this will be apparent to those skilled in the art.Cause
This, these modifications or improvements, belong to the scope of protection of present invention without departing from theon the basis of the spirit of the present invention.
Claims (10)
1. a kind of composition for oral cavity, which is characterized in that include the component of following parts by weight:
Rosemary leaf extract 0.05-5 parts by weight;
Leaf of Mentha piperita extract 0.1-2.5 parts by weight;
Medicine extracts of Salvia officinalis leaves 0.06-4 parts by weight.
2. composition according to claim 1, which is characterized in that the composition for oral cavity includes following parts by weight
Component:
Rosemary leaf extract 0.2-3 parts by weight;
Leaf of Mentha piperita extract 0.2-1.5 parts by weight;
Medicine extracts of Salvia officinalis leaves 0.1-2 parts by weight.
3. composition according to claim 1, which is characterized in that the composition further includes that anemarrhena asphodefoides extract, Cortex Phellodendri carry
It takes object, Baical Skullcap root P.E, coptis extract, shrubby sophora extract, capejasmine extract, Prunella vulgaris extract, Herba Lophatheri extract, wear
One or more of heart lotus extract, Honegsukle flower P.E, dandelion extract;
Preferably, dosage is each component in the composition:
It is further preferred that the composition for oral cavity includes the component of following parts by weight:
It is further preferred that the composition for oral cavity includes the component of following parts by weight:
4. preparing the oral cavity for treating bleeding gums, inhibiting oral bacteria according to any compositions of claim 1-3
Application in care product.
5. a kind of toothpaste, which is characterized in that include the component of following parts by weight:
Active component:
Rosemary leaf extract 0.05-5 parts by weight;
Leaf of Mentha piperita extract 0.1-2.5 parts by weight;
Medicine extracts of Salvia officinalis leaves 0.06-4 parts by weight;
Auxiliary material:
6. toothpaste according to claim 5, which is characterized in that include the component of following parts by weight:
Active component:
Rosemary leaf extract 0.2-3 parts by weight;
Leaf of Mentha piperita extract 0.2-1.5 parts by weight;
Medicine extracts of Salvia officinalis leaves 0.1-2 parts by weight;
Auxiliary material:
7. toothpaste according to claim 5, which is characterized in that the rubbing agent be selected from silica, hypophosphite monohydrate hydrogen calcium,
One or more of calcium phosphate dibasic anhydrous, calcium carbonate, aluminium hydroxide, sodium chloride or calcium pyrophosphate;
The moisturizer is selected from one or more of sorb (sugar) alcohol, glycerine, propylene glycol, polyethylene glycol-8 or butanediol;
The foaming agent be selected from lauryl sodium sulfate, sodium lauroyl sarcosine, sodium cocoyl glycinate, acyl glutamic acid sodium or
One or more of cocounut oil acyl methyl taurine sodium;
The thickener is selected from cellulose and its derivates, melon glue, sodium alginate, xanthans, guar hydroxypropyltrimonium
One or more of ammonium chloride, carrageenan or locust tree fresh kidney beans;
The sweetener is in saccharin sodium, Sucralose, xylitol, honey element, Aspartame, stevioside or mogroside
One or more;
The essence is selected from one or more of vanilla, spearmint, minty note or Chinese ilex peppermint;
The preservative is selected from benzoic acid and its esters, sorbic acid and one or more of its esters or parabens;
The appearance modifying agents are selected from titanium dioxide, food coloring, food color lake or one or more of the particle that cleans the teeth;
The solvent is selected from deionized water.
8. toothpaste according to claim 5, which is characterized in that the toothpaste further includes a kind of following ingredient:
9. a kind of mouthwash, which is characterized in that include the component of following parts by weight:
Active component:
Rosemary leaf extract 0.05-5 parts by weight;
Leaf of Mentha piperita extract 0.1-2.5 parts by weight;
Medicine extracts of Salvia officinalis leaves 0.06-4 parts by weight;
Auxiliary material:
10. mouthwash according to claim 9, which is characterized in that the solvent is selected from deionized water;
The moisturizer is selected from one or more of sorb (sugar) alcohol, propylene glycol, glycerine, polyethylene glycol-8;
The surfactant is selected from poloxamer188, lauryl sodium sulfate, sodium lauroyl sarcosine, cocounut oil acyl methyl ox
One or more of sodium sulfonate;
The thickener is selected from one or more of cellulose, card wave, carragheen;
The food flavor is selected from cloves, Chinese cassia tree perfume, fragrance of osmanthus, peppermint oil, vanilla, spearmint, minty note, Chinese ilex peppermint
One or more of;
The colorant is selected from one or more of green, blue, red;
It is furthermore preferred that above-mentioned mouthwash further includes following ingredient:
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810206265.5A CN108478500B (en) | 2018-03-13 | 2018-03-13 | Composition for oral cavity and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810206265.5A CN108478500B (en) | 2018-03-13 | 2018-03-13 | Composition for oral cavity and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108478500A true CN108478500A (en) | 2018-09-04 |
CN108478500B CN108478500B (en) | 2020-07-10 |
Family
ID=63339177
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810206265.5A Active CN108478500B (en) | 2018-03-13 | 2018-03-13 | Composition for oral cavity and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108478500B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114557932A (en) * | 2022-03-03 | 2022-05-31 | 李时珍医药集团有限公司 | Toothpaste containing folium artemisiae argyi and rosemary leaf extracts and preparation method thereof |
CN115252701A (en) * | 2022-03-04 | 2022-11-01 | 汪维武 | Oral liquid for inactivating helicobacter pylori and production method thereof |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101115531A (en) * | 2004-12-17 | 2008-01-30 | 高露洁-棕榄公司 | Oral compositions containing extracts of rosmarinus and related methods |
CN101780228A (en) * | 2010-04-20 | 2010-07-21 | 泰一和浦(北京)中医药研究院有限公司 | Traditional Chinese medicine composition for treating tinnitus and preparation method thereof |
CN101843882A (en) * | 2009-11-05 | 2010-09-29 | 泰一和浦(北京)中医药研究院有限公司 | Chinese medicinal composition for treating cholecystitis diseases and preparation method thereof |
JP5033283B2 (en) * | 2001-04-03 | 2012-09-26 | 日本ゼトック株式会社 | Oral composition |
CN104305180A (en) * | 2014-10-09 | 2015-01-28 | 张璧云 | Edible and applicable ingredient |
CN106265423A (en) * | 2016-08-23 | 2017-01-04 | 广州立白企业集团有限公司 | Having relieves inflammation or internal heat disappear pain effect oral care composition |
CN107375111A (en) * | 2017-08-30 | 2017-11-24 | 陈彦彪 | A kind of soluble anti-acne micropin |
-
2018
- 2018-03-13 CN CN201810206265.5A patent/CN108478500B/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5033283B2 (en) * | 2001-04-03 | 2012-09-26 | 日本ゼトック株式会社 | Oral composition |
CN101115531A (en) * | 2004-12-17 | 2008-01-30 | 高露洁-棕榄公司 | Oral compositions containing extracts of rosmarinus and related methods |
CN101843882A (en) * | 2009-11-05 | 2010-09-29 | 泰一和浦(北京)中医药研究院有限公司 | Chinese medicinal composition for treating cholecystitis diseases and preparation method thereof |
CN101780228A (en) * | 2010-04-20 | 2010-07-21 | 泰一和浦(北京)中医药研究院有限公司 | Traditional Chinese medicine composition for treating tinnitus and preparation method thereof |
CN104305180A (en) * | 2014-10-09 | 2015-01-28 | 张璧云 | Edible and applicable ingredient |
CN106265423A (en) * | 2016-08-23 | 2017-01-04 | 广州立白企业集团有限公司 | Having relieves inflammation or internal heat disappear pain effect oral care composition |
CN107375111A (en) * | 2017-08-30 | 2017-11-24 | 陈彦彪 | A kind of soluble anti-acne micropin |
Non-Patent Citations (2)
Title |
---|
云南省餐饮文化与美食行业协会: "《滇香四溢》", 31 July 2016, 云南科技出版社 * |
颜红侠等: "《日用化妆品制造原理与技术》", 31 July 2004 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114557932A (en) * | 2022-03-03 | 2022-05-31 | 李时珍医药集团有限公司 | Toothpaste containing folium artemisiae argyi and rosemary leaf extracts and preparation method thereof |
CN115252701A (en) * | 2022-03-04 | 2022-11-01 | 汪维武 | Oral liquid for inactivating helicobacter pylori and production method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN108478500B (en) | 2020-07-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101181548B (en) | A medicinal or health composition containing natural antibacterial agent | |
CN108606939B (en) | Composition with oral health care function and application and preparation method thereof | |
CN102151241B (en) | Toothpaste containing natural plant extractive and preparation method thereof | |
CN104435379B (en) | A kind of plant extract complex with antibacterial anti-inflammatory, hemostasis and pain relieving and application thereof | |
CN103585433B (en) | Traditional Chinese medicine composition for treating oral ulcer | |
CN103767965A (en) | Forsythia suspensa leaf hand sanitizer and preparation method thereof | |
CN102579525A (en) | Ilex rotunda thunb extract and preparation method and application thereof | |
CN102940595A (en) | Mouthwash with functions of antibiosis, antiphlogosis and deodorization, and preparation method and use thereof | |
CN107648166A (en) | Natural nano toothpaste | |
CN112868678A (en) | Plant antibacterial mite-killing agent, preparation method thereof and daily necessities containing plant antibacterial mite-killing agent | |
CN105456112B (en) | A kind of oral cavity washing product of anti-candida albicanses | |
CN101181208B (en) | Gargle containing natural antibiotics and preparation method thereof | |
CN108653081A (en) | Compound Jin jasmine tea mouthwash and preparation method thereof | |
CN100581534C (en) | Galangal rhizome extract preparation process | |
JPH0616530A (en) | Cosmetic | |
CN108478500A (en) | A kind of composition and its application for oral cavity | |
CN107929428B (en) | Composition for oral cavity and application thereof | |
CN103505395B (en) | Forsythia leaf traditional Chinese medicinal toothpaste | |
CN107913234B (en) | Pilose antler grass toothpaste and preparation method thereof | |
CN112716854B (en) | Traditional Chinese medicine toothpaste and preparation method thereof | |
KR100388668B1 (en) | The preparation method of the solid-type functional food | |
CN108066224A (en) | A kind of peace stomach ulcer toothpaste and preparation method thereof | |
CN113616801A (en) | Preparation method and application of antiseptic and antibacterial preparation containing Scutellariae radix extract | |
CN113520957A (en) | Chinese herbal medicine toothpaste formula for gingivitis and gingival atrophy and preparation method thereof | |
CN104606105A (en) | Plant nanoemulsion toothpaste |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |